Ugly Stick Set to Tee-off on Endo Health (ENDP) Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Piper Jaffray Downgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Neutral
January 4, 2013 7:28 AM ESTPiper Jaffray downgraded Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) from Overweight to Neutral with a price target of $28.00 (from $37.00).
For an analyst ratings summary and ratings history on Endo Pharmaceuticals Holdings Inc click... More
Endo Health (ENDP) Guides 2013 EPS Below Street
January 3, 2013 4:35 PM ESTEndo Health Solutions (Nasdaq: ENDP) today reaffirmed its non-GAAP 2012 financial outlook, commented on certain expected 2012 GAAP charges, and provided its current outlook for non-GAAP financial performance for the full year ending December 31, 2013.
Endo continues to expect that 2012 adjusted diluted earnings per share (EPS) will be at or below the low end of its previous guidance range of $5.00 to $5.10. In addition, as part of the company's regular financial reporting process, it expects to record in fiscal 2012, certain pre-tax GAAP charges, including a non-cash asset impairment charge related primarily to goodwill attributable to the company's... More
